Search Results

You searched for : cisplatin

	From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer Patients This paradigm shift promises not only to improve survival rates but also to enhance the quality of life for patients and their families.... Dec 23
	Chemotherapy Drug Linked to Long-Term Hearing Loss in Cancer Survivors Researchers hope that these findings will encourage the exploration of alternative chemotherapy protocols that reduce the risk of hearing loss. This includes preventive measures and ... Jul 05
	Venus Remedies consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines The $4.20-billion pharmaceutical market of the Philippines accounts for a significant market for Venus Remedies from the ASEAN region as the company moves ... Nov 04
	European Commission approves Teysuno in metastatic colorectal cancer Latest Corporate news updates; Pharma Feb 3rd 2022... Feb 03
	Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma ... Jul 17
	Debiopharm grants exclusive license to Merck for Xevinapant This worldwide exclusive license to Merck KGaA, Darmstadt, Germany for the development and commercialization of Xevinapant ... Mar 03
	FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab) Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI™ (rituximab-arrx), a biosimilar to Rituxan® (rituximab)... Dec 18
	Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer... Oct 24
	US FDA approves drug combination for treating mesothelioma US FDA approved for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery... Oct 05
	Lupin Launches Fosaprepitant for injection ; emetogenic cancer chemotherapy 150 mg Single-Dose Vial, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.... Sep 28
	After Japan, EU also approves Imfinzi for lungs cancer After Japan, EU approves AstraZeneca Imfinzi , along with chemotherapy it could treat small cell lung cancer... Sep 02
	Imfinzi from AstraZeneca approved in Japan for lung cancer treatment Imfinzi gets approval in Japan currently FDA has issued it Priority Review status for lungs and bladder cancer treatment... Aug 21
	Green tea -For weightloss and more ... Mar 09
	ERBITUX Approved for First-line Use in China in Patients With Recurrent and/ Metastatic Squamous Cell Carcinoma of the Head and Neck Approval is for ERBITUX in combination with platinum-based therapy with fluorouracil for the first-line treatment of Head and Neck cancer... Mar 03
	Council for Healthcare and Pharma Emphasizes Need to Strengthen System for Treatment of Paediatric Cancers Headquartered in New Delhi, India, CHP focuses on Africa, Brazil, China, Germany, India, Japan, UK and the USA. Its important areas of work are in ... Feb 17
	Neuroblastoma drug goes through successful drug trials Aptorum Group Limited , a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in ... Feb 12
	IASLC World Conference on Lung Cancer--Summary of the Presidential Symposium Research This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. ... Sep 12
17 Matching result(s) found!

-Advertisements-

Trending Now
	Stethoscopes in the Line of Fire: India’s Medical Army Prepares for CrisisMay 10, 2025
	Prescription Denied: Why Heart Failure Patients in India Aren’t Getting the Right MedicinesMay 10, 2025
	Nipah Returns: How One Woman’s Diagnosis Sparked a Statewide Health EmergencyMay 10, 2025
	Is Teleconsultation Legit? How to Choose the Right Online DoctorMay 10, 2025
	Ozempic, Mounjaro, and the Weight Loss Drug Revolution: What Patients Need to KnowMay 10, 2025
	IGP Launches Flower Fiesta and Creative Workshops to Celebrate Moms NationwideMay 09, 2025
	Conflicts and crises intensify the need for gender equality and health equityMay 09, 2025
	Swipe. Click. Risk? When Medicines Arrive Faster Than Rules Can Keep UpMay 09, 2025
	Biological Age vs Real Age: What If Your Body Is Lying to You?May 09, 2025
	Turn Up the Volume, Turn Down the Fat: The Sonic Slimming ScienceMay 09, 2025
	A Glimpse into the Eyes to Save the Kidneys: AI's Revolutionary Advancement in Diabetic CareMay 08, 2025
	Will Weight-Loss Drugs Solve the Obesity Crisis or Just Create More Problems?May 08, 2025
	Could ₹37 Crore in Funding Be the Secret to Unlocking the Future of Healthcare Benefits?May 08, 2025
	A film on the incredibly rare and endangered Cantor’s giant softshell turtle found in Kerala wins Best Documentary – Jury Award at the prestigious 15th Dada Saheb Phalke Film Festival 2025May 08, 2025
	Everest Medicines Limited Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in ChinaMay 08, 2025
	Is Irregular Periods Normal: What Every Woman Should Know, According to a GynecologistMay 08, 2025
	India Marks World Thalassaemia Day Amidst Rising Concerns Over Access to CareMay 07, 2025
	CARE Hospitals, Hi-Tec City Hosts a ‘MOM’orable Celebration Ahead of Mother’s DayMay 07, 2025
	Plastics in Our Bloodstream: Are We Paying for Convenience with Our Hearts?May 07, 2025
	The Sparkling Lie or the Secret Elixir? Champagne and Cardiac Claims Under the MicroscopeMay 07, 2025

Search Results

From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer Patients

Chemotherapy Drug Linked to Long-Term Hearing Loss in Cancer Survivors

Venus Remedies consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines

European Commission approves Teysuno in metastatic colorectal cancer

Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma

Debiopharm grants exclusive license to Merck for Xevinapant

FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)

Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer

US FDA approves drug combination for treating mesothelioma

Lupin Launches Fosaprepitant for injection ; emetogenic cancer chemotherapy

After Japan, EU also approves Imfinzi for lungs cancer

Imfinzi from AstraZeneca approved in Japan for lung cancer treatment

Green tea -For weightloss and more

ERBITUX Approved for First-line Use in China in Patients With Recurrent and/ Metastatic Squamous Cell Carcinoma of the Head and Neck

Council for Healthcare and Pharma Emphasizes Need to Strengthen System for Treatment of Paediatric Cancers

Neuroblastoma drug goes through successful drug trials

IASLC World Conference on Lung Cancer--Summary of the Presidential Symposium Research

Trending Now